Document is current
Any future updates will be listed below
-
Authors
Popovic, Djordje S.
Patoulias, Dimitrios
Koufakis, Theocharis
Karakasis, Paschalis
Papanas, Nikolaos https://orcid.org/0000-0002-7320-785X
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 24 September 2024
First Online: 16 October 2024
Declarations
:
: Djordje S. Popovic declares associations with: Abbott, Alkaloid, Amicus, AstraZeneca, Boehringer Ingelheim, Berlin-Chemie, Eli Lilly, Galenika, Krka, Merck, Novo Nordisk, PharmaSwiss, Sanofi-Aventis, Servier, Viatris, and Wörwag Pharma. Theocharis Koufakis has received honoraria for lectures from AstraZeneca, Boehringer-Ingelheim, Pharmaserve Lilly, and Novo Nordisk, for advisory boards from Novo Nordisk and Boehringer-Ingelheim, and has participated in sponsored studies by Eli Lilly and Novo Nordisk. Nikolaos Papanas has been an advisory board member of Astra-Zeneca, Boehringer Ingelheim, Menarini, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by Astra-Zeneca, Eli-Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for Astra-Zeneca, Boehringer Ingelheim, Eli-Lilly, Elpen, Menarini, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis and Vianex; and has attended conferences sponsored by TrigoCare International, Eli-Lilly, Galenica, Novo Nordisk, Pfizer and Sanofi-Aventis. Nikolaos Papanas is an Editorial Board member of Diabetes Therapy. Nikolaos Papanas was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dimitrios Patoulias and Paschalis Karakasis declare no conflict of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
